Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 29 articles: HTML format

Single Articles

September 2026
1. HE H, Hu Y, Lu Y, Deng M, et al
   PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance.
   Cancer Res. 2026;86:4645-4662.
   PubMed     Abstract available
   
   
   July 2026
2. DU W, Ding L, Zhu J, Li L, et al
   Lactylation Orchestrates Immune Evasion in Gastric Cancer through KDM5B-Mediated Histone Demethylation.
   Cancer Res. 2026 Jul 23:OF1-OF19. doi: 10.1158/0008-5472.CAN-25-5071.
   PubMed     Abstract available
   
   
   
3. FENG H, Ling F, Xi Z, Li R, et al
   Targeting DOT1L Reactivates HERV-K to Drive Cell-Autonomous and Paracrine Senescence in Adenocarcinoma of the Esophagogastric Junction.
   Cancer Res. 2026;86:3588-3603.
   PubMed     Abstract available
   
   
   February 2026
4. WANG Q, Xu P, Chen J, Yang S, et al
   Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer.
   Cancer Res. 2026 Feb 24. doi: 10.1158/0008-5472.CAN-25-3071.
   PubMed     Abstract available
   
   
   
5. LU Y, Wu X, Li B, Yao L, et al
   GAL3ST1-Mediated Histone Tyrosine Sulfation Induced by Cancer-Associated Fibroblasts Promotes Gastric Cancer Metastasis.
   Cancer Res. 2026 Feb 13. doi: 10.1158/0008-5472.CAN-25-2452.
   PubMed     Abstract available
   
   
   January 2026
6. LIU X, Chen B, Xie F, Wong KY, et al
   Correction: FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.
   Cancer Res. 2026;86:556.
   PubMed    
   
   
   
7. QIN ZY, Che LR, Tian S, Li X, et al
   TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex That Drives Invasiveness of Gastric Adenocarcinoma.
   Cancer Res. 2026;86:402-420.
   PubMed     Abstract available
   
   
   
8. LIAO F, Tong Y, Sun H, Chen S, et al
   Nerves Stimulates Crosstalk between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.
   Cancer Res. 2026 Jan 14. doi: 10.1158/0008-5472.CAN-25-3092.
   PubMed     Abstract available
   
   
   October 2025
9. WU W, Xun Z, Han Y, Chen Q, et al
   Artificial Intelligence and Multi-modality Data Integration Deciphers Tertiary Lymphoid Structure Maturity in Gastric Cancer.
   Cancer Res. 2025 Oct 28. doi: 10.1158/0008-5472.CAN-25-1793.
   PubMed     Abstract available
   
   
   
10. WANG Q, Zhong L, Wang X, Zhang Z, et al
    RORgamma Hijacks HIF-1alpha to Promote Peritoneal Metastasis of Gastric Cancer.
    Cancer Res. 2025 Oct 23. doi: 10.1158/0008-5472.CAN-25-1690.
    PubMed     Abstract available
    
    
    
11. XU Y, Ye Z, Lin Z, Qian X, et al
    Disrupting Paraspeckle Stability by Targeting WTX-NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer.
    Cancer Res. 2025 Oct 20. doi: 10.1158/0008-5472.CAN-25-1747.
    PubMed     Abstract available
    
    
    September 2025
12. KIM J, Shrestha C, Lee G, Jung D, et al
    Condensation of the Golgi Apparatus Activates YAP1 to Promote Gastric Cancer Progression.
    Cancer Res. 2025 Sep 8. doi: 10.1158/0008-5472.CAN-24-3920.
    PubMed     Abstract available
    
    
    August 2025
13. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    PubMed     Abstract available
    
    
    May 2025
14. XU X, Yan C, Bian L, Li Z, et al
    Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer.
    Cancer Res. 2025 May 16. doi: 10.1158/0008-5472.CAN-24-4065.
    PubMed     Abstract available
    
    
    
15. KUAI X, Li L, Chen R, Wang K, et al
    Correction: SCFFBXW7/GSK3beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.
    Cancer Res. 2025;85:1739.
    PubMed    
    
    
    April 2025
16. QIU B, Zheng Y, Liu S, Song R, et al
    Multi-task Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4190.
    PubMed     Abstract available
    
    
    March 2025
17. LIN GT, Yan C, Li LJ, Qiu XW, et al
    Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.
    Cancer Res. 2025 Mar 7. doi: 10.1158/0008-5472.CAN-24-2697.
    PubMed     Abstract available
    
    
    February 2025
18. ZHANG T, Li Y, Zhai E, Zhao R, et al
    Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2580.
    PubMed     Abstract available
    
    
    October 2024
19. CUI Y, Chang Y, Ma X, Sun M, et al
    Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
    PubMed     Abstract available
    
    
    July 2024
20. LIU X, Chen B, Xie F, Wong KY, et al
    FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3074.
    PubMed     Abstract available
    
    
    
21. LIU S, Lin C, Lin X, Lin P, et al
    NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-4062.
    PubMed     Abstract available
    
    
    
22. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    PubMed     Abstract available
    
    
    December 2023
23. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    PubMed     Abstract available
    
    
    September 2023
24. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    PubMed     Abstract available
    
    
    August 2023
25. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    PubMed     Abstract available
    
    
    May 2023
26. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    PubMed     Abstract available
    
    
    March 2023
27. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    PubMed    
    
    
    
28. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    PubMed     Abstract available
    
    
    
29. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum